- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.06. | Lilly and Hanmi sign $1.26bn licensing deal for sonefpeglutide | ||
| 01.06. | FDA approves AstraZeneca's Imfinzi-BCG combination for NMIBC therapy | ||
| 29.05. | GSK's Nucala secures NICE COPD endorsement | ||
| 29.05. | Pfizer and Innovent Biologics sign $10.5bn cancer drug development deal | ||
| 29.05. | FDA grants priority review for Sanofi's venglustat NDA | ||
| 28.05. | FDA oncology roundup: AbbVie's rare cancer approval, AstraZeneca in breast cancer limbo | ||
| 27.05. | California startup Protuoso raises $9.5m for "mix-and-match" drug platform | ||
| 27.05. | Kardigan targets IPO to support cardiology pipeline progression | ||
| 27.05. | Autobahn's elunetirom receives FDA fast track designation to treat adjunctive bipolar | ||
| 27.05. | SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative | ||
| 26.05. | EMA recommends approvals for both oral and high-dose pen of Wegovy | ||
| 26.05. | Eli Lilly to buy trio of vaccine developers in $3.8bn outlay | ||
| 26.05. | University of Edinburgh develops cell therapy for liver disease | ||
| 26.05. | Pierre Fabre's Braftovi gains CHMP positive opinion for mCRC | ||
| 25.05. | AstraZeneca, Daiichi Sankyo's Datroway receives FDA approval for TNBC | ||
| 22.05. | CVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati | ||
| 22.05. | European STI cases reach record high amid testing and prevention gaps | ||
| 22.05. | Gilead Sciences acquires Tubulis for $5bn | ||
| 22.05. | Concept Life Sciences and OpenBench partner on drug discovery services | ||
| 21.05. | Gilead teams up with WHO again to eliminate parasitic tropical disease | ||
| 21.05. | Eli Lilly maintains M&A streak with $202m Engage Bio buyout | ||
| 21.05. | FUJIFILM opens new iPSC facility in Madison, US | ||
| 21.05. | BMS and Anthropic collaborate for Claude implementation | ||
| 20.05. | Investment giants join forces to form largest healthcare firm on the globe | ||
| 20.05. | Clinical Trials Day 2026: 'Research Rising' theme reflected in Q1 study growth |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.